Munich, July 15, 2014 - Elsevier, a world-leading provider of scientific, technical and medical information products and services, is pleased to announce the launch of open access journal Burnout Research.
Burnout has proven its global significance and impact over the last years, posing major challenges for society. Not only in the scientific community, but also at a governmental level and within public and private organizations, the significance of the issue is acknowledged and there is a growing interest in and need for developing interventions to reduce prevalence rates. As such, increasing amounts of cross-disciplinary research is being conducted across the globe to gain further understanding of the phenomenon, its symptoms and ways of treatment.
"With the launch of Burnout Research, we want to create one central place where the larger burnout community, from researchers to practitioners, policy-makers and other individuals outside the scientific community, can share new ideas and information, discuss and debate theories and applications, and propose new directions for research and interventions," explained Editor-in-Chief of the journal, Professor Christina Maslach of the University of Berkeley, California.
Frauke Muenzel, Publisher at Elsevier said, "As the first journal dedicated to understanding the causes of burnout and potential solutions to the problem, Burnout Research aims to be a global forum, not only for researchers, but also for those directly or indirectly effected by burnout. We are happy to support the editors in making the journal's content as widely available as possible."
Articles published in Burnout Research are published open access. The first issue of Burnout Research is now available on ScienceDirect.
For more information or to submit an article, go to: http://www.
About Open Access Publishing at Elsevier
Elsevier has been providing open access publishing options since 2005. Today, researchers can choose to publish open access in over 1,500 established peer-reviewed journals as well as over 100 open access journals and these numbers will continue to grow rapidly. All of Elsevier's open access publications have been peer reviewed, ensuring that the broader community not only reads the latest research but that it is factual, original and of the highest quality and ethical standards. For more information about Elsevier's open access program, visit http://www.
Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions -- among them ScienceDirect, Scopus, Elsevier Research Intelligence and ClinicalKey -- and publishes nearly 2,200 journals, including The Lancet and Cell, and over 25,000 book titles, including a number of iconic reference works.
The company is part of Reed Elsevier Group PLC, a world-leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).
+49 174 344 2281